It was found that EVs derived from the cancer cells deliver miR-181c which promotes the destruction of BBB by downregulating its target gene 3-Phosphoinositide dependant Protein Kinase 1 (PDPK1), leading to the abnormal localisation of actin. This evidence concerns the gene PDPK1 and cancer.